McKesson (MCK) Stock Forecast & Price Target

McKesson
Bear Case

Investors should be bearish about investing in McKesson Co. for these reasons:

• Insider selling has been notable, with EVP Francisco Fraga selling 650 shares at an average price of $1,102.96 in November 2026 and CEO Brian S Tyler selling 8,463 shares in July 2026, which may signal that company executives are taking advantage of the recent stock price appreciation to reduce their personal holdings.
• Some analysts remain cautious, with RBC Capital maintaining a Sector Perform rating and setting a price target of $965, which is below the current stock price of $1,059.43, suggesting that the recent rally may have priced in much of the positive news and leaving limited upside for new investors.
• The company reported a negative return on equity of 202.94% for the recent quarter, which, while potentially influenced by accounting adjustments or debt structures, is a metric that investors should scrutinize as it indicates a complex relationship between equity and earnings that may not reflect straightforward profitability.
• Short interest, while low at approximately 1.97% of the float, has shown some volatility in recent months, with shares shorted increasing to 2,298,518 in the latest reporting period, indicating that some market participants are still betting against the stock's continued rise.
• The stock's price-to-earnings ratio of 27.24 is relatively high, which may limit the margin of safety for investors if growth slows or if the market becomes less favorable to healthcare distribution stocks, making the valuation sensitive to any disappointment in future earnings.